AstraZeneca Investor Day Presentation Deck

ASCO GI 2022 ASCO Gastrointestinal Cancers Symposium 7 21 abstracts with Four oral presentations Two Proffered paper oral presentations (late breakers) Two Mini oral presentations 17 Posters 21 Abstracts Source: ASCO GI 2022 accepted abstracts. Inclusive of externally sponsored research and partner-led trials. HCC = hepatocellular carcinoma; BTC = biliary tract cancer; CRC = colorectal cancer. ● Data highlights Imfinzi +/- tremelimumab in HCC HIMALAYA Study 22 Imfinzi in BTC TOPAZ-1 Enhertu DESTINY-Gastric01, DESTINY- Gastric03, DESTINY-CRC01 $

View entire presentation